<p><strong>中國儒意控股有限公司</strong> (HKG:136) 的股東在看到股價在上個季度下跌 15% 後可能會感到擔憂。另一方面，股價仍高於三年前的水平。可以説，購買指數基金可能會更划算，因為三年內 18% 的收益並不算驚人。</p>
<p>由於中國儒意控股的股東這一週表現強勁，讓我們來看看長期基本面的趨勢。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p>引用巴菲特的話，'船隻將環遊世界，但平面地球協會將蓬勃發展。市場上價格與價值之間將繼續存在巨大差異...' 考慮市場對公司看法變化的一種不完美但簡單的方法是比較每股收益（EPS）的變化與股價變動。</p>
<p>在過去三年中，中國儒意控股未能實現每股收益的增長，反而下降了 45%（年化）。</p>
<p>這意味着市場不太可能根據盈利增長來評估公司。由於每股收益的變化似乎與股價變化無關，因此值得關注其他指標。</p>
<p>每年 40% 的收入增長可能被視為中國儒意控股正在增長的證據。如果公司是為了長期利益而管理的，那麼今天的股東可能是對的，值得持有。</p>
<p>您可以在下面看到收益和收入隨時間的變化（通過點擊圖片發現確切的數值）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/882017-earnings-and-revenue-growth-1-dark-2/1768261297620?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/882017-earnings-and-revenue-growth-1-dark-2/1768261297620"/></p>
<p>SEHK:136 收益和收入增長 2026 年 1 月 12 日</p>
<p>我們知道中國儒意控股最近改善了其底線，但未來會怎樣呢？您可以在這個 <strong>互動</strong> 圖表中查看分析師對中國儒意控股未來利潤的預測。</p>
<h2>不同的視角</h2>
<p>儘管大盤在過去一年上漲了約 41%，但中國儒意控股的股東卻損失了 6.0%。即使是優質股票的股價有時也會下跌，但在我們對基本面指標產生濃厚興趣之前，我們希望看到業務的基本面有所改善。遺憾的是，去年的表現結束了一段糟糕的時期，股東在五年內面臨每年 1.9% 的總損失。我們意識到巴倫·羅斯柴爾德曾説過投資者應該在 “街上有血時買入”，但我們提醒投資者首先要確保他們購買的是高質量的企業。雖然考慮市場條件對股價的不同影響是非常重要的，但還有其他因素更為重要。例如，投資風險的無處不在的陰影。<strong>我們已識別出中國儒意控股的 1 個警示信號</strong>，理解這些信號應該是您投資過程的一部分。</p>
<p>當然，<strong>中國儒意控股可能不是最佳的購買股票</strong>。因此，您可能希望查看這份 <strong>免費的</strong> 成長股集合。</p>
<p><em>請注意，本文中引用的市場回報反映了目前在香港交易所交易的股票的市場加權平均回報。</em></p>

中國儒意

<p>中國儒意控股（HKG:136）的股東在過去三年中實現了 5.5% 的年複合增長率，儘管上個季度股價下跌了 15%，每股收益下降了 45%。儘管收入年增長率達到了 40%，但該股票的表現仍落後於大盤，後者去年上漲了 41%。股東在過去五年中面臨了每年 1.9% 的總損失。分析師建議因投資風險保持謹慎，並指出該公司存在一個警示信號</p>

<p><strong>China Ruyi Holdings Limited</strong> (HKG:136) shareholders might be concerned after seeing the share price drop 15% in the last quarter. On the other hand the share price is higher than it was three years ago. Arguably you'd have been better off buying an index fund, because the gain of 18% in three years isn't amazing.</p>
<div class="lb-trans"><p><strong>中國儒意控股有限公司</strong> (HKG:136) 的股東在看到股價在上個季度下跌 15% 後可能會感到擔憂。另一方面，股價仍高於三年前的水平。可以説，購買指數基金可能會更划算，因為三年內 18% 的收益並不算驚人。</p>
</div><p>Since it's been a strong week for China Ruyi Holdings shareholders, let's have a look at trend of the longer term fundamentals.</p>
<div class="lb-trans"><p>由於中國儒意控股的股東這一週表現強勁，讓我們來看看長期基本面的趨勢。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p>To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.</p>
<div class="lb-trans"><p>引用巴菲特的話，'船隻將環遊世界，但平面地球協會將蓬勃發展。市場上價格與價值之間將繼續存在巨大差異...' 考慮市場對公司看法變化的一種不完美但簡單的方法是比較每股收益（EPS）的變化與股價變動。</p>
</div><p>Over the last three years, China Ruyi Holdings failed to grow earnings per share, which fell 45% (annualized).</p>
<div class="lb-trans"><p>在過去三年中，中國儒意控股未能實現每股收益的增長，反而下降了 45%（年化）。</p>
</div><p>This means it's unlikely the market is judging the company based on earnings growth. Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.</p>
<div class="lb-trans"><p>這意味着市場不太可能根據盈利增長來評估公司。由於每股收益的變化似乎與股價變化無關，因此值得關注其他指標。</p>
</div><p>It could be that the revenue growth of 40% per year is viewed as evidence that China Ruyi Holdings is growing. If the company is being managed for the long term good, today's shareholders might be right to hold on.</p>
<div class="lb-trans"><p>每年 40% 的收入增長可能被視為中國儒意控股正在增長的證據。如果公司是為了長期利益而管理的，那麼今天的股東可能是對的，值得持有。</p>
</div><p>You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).</p>
<div class="lb-trans"><p>您可以在下面看到收益和收入隨時間的變化（通過點擊圖片發現確切的數值）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/882017-earnings-and-revenue-growth-1-dark-2/1768261297620" alt="" original-src="https://images.simplywall.st/asset/chart/882017-earnings-and-revenue-growth-1-dark-2/1768261297620"/></p>
<p>SEHK:136 Earnings and Revenue Growth January 12th 2026</p>
<div class="lb-trans"><p>SEHK:136 收益和收入增長 2026 年 1 月 12 日</p>
</div><p>We know that China Ruyi Holdings has improved its bottom line lately, but what does the future have in store? You can see what analysts are predicting for China Ruyi Holdings in this <strong>interactive</strong> graph of future profit estimates.</p>
<div class="lb-trans"><p>我們知道中國儒意控股最近改善了其底線，但未來會怎樣呢？您可以在這個 <strong>互動</strong> 圖表中查看分析師對中國儒意控股未來利潤的預測。</p>
</div><h2>A Different Perspective</h2>
<div class="lb-trans"><h2>不同的視角</h2>
</div><p>While the broader market gained around 41% in the last year, China Ruyi Holdings shareholders lost 6.0%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 1.9% per year over five years. We realise that Baron Rothschild has said investors should &#34;buy when there is blood on the streets&#34;, but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. <strong>We've identified 1 warning sign</strong> with China Ruyi Holdings , and understanding them should be part of your investment process.</p>
<div class="lb-trans"><p>儘管大盤在過去一年上漲了約 41%，但中國儒意控股的股東卻損失了 6.0%。即使是優質股票的股價有時也會下跌，但在我們對基本面指標產生濃厚興趣之前，我們希望看到業務的基本面有所改善。遺憾的是，去年的表現結束了一段糟糕的時期，股東在五年內面臨每年 1.9% 的總損失。我們意識到巴倫·羅斯柴爾德曾説過投資者應該在 “街上有血時買入”，但我們提醒投資者首先要確保他們購買的是高質量的企業。雖然考慮市場條件對股價的不同影響是非常重要的，但還有其他因素更為重要。例如，投資風險的無處不在的陰影。<strong>我們已識別出中國儒意控股的 1 個警示信號</strong>，理解這些信號應該是您投資過程的一部分。</p>
</div><p>Of course <strong>China Ruyi Holdings may not be the best stock to buy</strong>. So you may wish to see this <strong>free</strong> collection of growth stocks.</p>
<div class="lb-trans"><p>當然，<strong>中國儒意控股可能不是最佳的購買股票</strong>。因此，您可能希望查看這份 <strong>免費的</strong> 成長股集合。</p>
</div><p><em>Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Hong Kong exchanges.</em></p>
<div class="lb-trans"><p><em>請注意，本文中引用的市場回報反映了目前在香港交易所交易的股票的市場加權平均回報。</em></p>
</div>

中國儒意控股（HKG:136）的股東在過去三年中實現了 5.5% 的年複合增長率，然而其收益卻在不斷縮減